NCT01432223View on ClinicalTrials.gov

Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

May 31, 2014

Conditions
Breast CancerHER-2 Positive Breast CancerEffects of Chemotherapy
Interventions
DRUG

Nab-paclitaxel

Nab-paclitaxel 260mg/m2 q3w

Trial Locations (1)

5698686

Osaka Medical College, Takatsuki

Sponsors
All Listed Sponsors
lead

Osaka Medical College

OTHER